Tag: personalized medicine market analysis

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Latest Market Insights for the Personalized Medicine Industry?

Over the past few years, the size of the personalized medicine market has expanded significantly. The market, which stood at $386.27 billion in 2024, is projected to increase to $422.9 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.5%. The historical growth trends in this market can be linked to the emergence of companion diagnostics, the focus on patient-centric healthcare, a shift in the paradigm of drug development, efforts to contain healthcare costs, and the rising incidence of chronic diseases.

The market for personalized medicine is predicted to expand considerably in the coming years, growing to “$650.59 billion in 2029 with a compound annual growth rate (CAGR) of 11.4%.” This surge in the predicted period can be credited to ongoing advances in genomics, the broadening of biomarker identification, the rising use of telemedicine, supportive regulatory frameworks, and collaboration and information sharing. The forecast period will witness major trends such as the incorporation of artificial intelligence (AI), progress in genomic sequencing, data amalgamation and analysis, immunotherapy and specific therapies, the enhancement of patient authority and educated decision-making, and collaborations and alliances.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10272&type=smp

What Forces Are Driving The Growth Of The Personalized Medicine Industry?

The uptick in rare diseases is anticipated to fuel the expansion of the personalized medicine market. This surge corresponds to an increasing count of individuals identified with conditions such as Klinefelter Syndrome, Aarskog Syndrome, and Abetalipoproteinemia. Personalized medicine offers bespoke treatment strategies, catering to the exclusive needs of patients with rare diseases. To illustrate, the Genetic Alliance UK, a national charity based in the UK dedicated to helping those affected by genetic, rare and undiagnosed conditions, reported in February 2024 that 3.5 million people in the UK are living with a rare disease and 1 in 17 individuals will at some stage in their life be impacted by a rare condition. Hence, as the escalated prevalence of rare diseases persists, it is fostering the growth of the personalized medicine market.

The personalized medicine market covered in this report is segmented –

1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness

2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications

3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users

Subsegments:

1) By Personalized Medicine Diagnostics: Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging

2) By Personalized Medicine Therapeutics: Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products

3) By Personalized Medical Care: Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring

4) By Personalized Nutrition And Wellness: Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs

What Trends Are Currently Influencing Growth In The Personalized Medicine Market?

Advancements in technology are emerging as a dominant trend in the personalized medicine sector. The implementation of novel technologies is being leveraged by leading companies in the personalized medicine market to maintain their market position. For instance, OM1, a healthcare firm based in the US that uses real-world data and artificial intelligence (AI) to support healthcare providers, registered a patent for an AI-driven platform in April 2023 to promote personalized medicine. This innovation makes use of wide-scale data analysis to draw valuable conclusions about diagnoses, disease progression, and treatment responses. It is particularly valuable because it provides customized healthcare information, improves healthcare providers’ decision-making process, and speeds up clinical trials by efficiently identifying suitable candidates, leading to the further progression of personalized medicine in the market.

Who Are The Primary Players Operating Across The Global Personalized Medicine Market?

Major companies operating in the personalized medicine market include Bayer AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, AstraZeneca plc, Abbott Laboratories, Danaher Corporation, Eli Lilly and Company, Decode Genetics Inc., GE HealthCare Technologies Inc., Roche Diagnostics, Genentech Inc., Biogen Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Myriad Genetics Inc., Verily Life Sciences LLC, Guardant Health Inc., Tempus Labs, Oxford Nanopore Technologies, Foundation Medicine Inc., NanoString Technologies Inc., Exagen Inc., Asuragen Inc., Personal Genome Diagnostics, Precision Biologics Inc., Strata Oncology, Genelex Corp, Invitae Corporation, Color Genomics, Helix OpCo LLC, 10x Genomics Inc., Agena Bioscience Inc., Natera Inc., Becton Dickinson and Company, PerkinElmer Inc., Sophia Genetics, Genomic Vision, Personalis Inc.

https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report

Which Region Offers The Most Growth Potential For The Personalized Medicine Market Through 2029?

North America was the largest region in the personalized medicine market in 2024. Asia-pacific is expected to be the fastest-growing region in the global personalized medicine market during the forecast period. The regions covered in the personalized medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10272&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Latest Market Insights for the Personalized Medicine Industry?

Over the past few years, the size of the personalized medicine market has expanded significantly. The market, which stood at $386.27 billion in 2024, is projected to increase to $422.9 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.5%. The historical growth trends in this market can be linked to the emergence of companion diagnostics, the focus on patient-centric healthcare, a shift in the paradigm of drug development, efforts to contain healthcare costs, and the rising incidence of chronic diseases.

The market for personalized medicine is predicted to expand considerably in the coming years, growing to “$650.59 billion in 2029 with a compound annual growth rate (CAGR) of 11.4%.” This surge in the predicted period can be credited to ongoing advances in genomics, the broadening of biomarker identification, the rising use of telemedicine, supportive regulatory frameworks, and collaboration and information sharing. The forecast period will witness major trends such as the incorporation of artificial intelligence (AI), progress in genomic sequencing, data amalgamation and analysis, immunotherapy and specific therapies, the enhancement of patient authority and educated decision-making, and collaborations and alliances.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10272&type=smp

What Forces Are Driving The Growth Of The Personalized Medicine Industry?

The uptick in rare diseases is anticipated to fuel the expansion of the personalized medicine market. This surge corresponds to an increasing count of individuals identified with conditions such as Klinefelter Syndrome, Aarskog Syndrome, and Abetalipoproteinemia. Personalized medicine offers bespoke treatment strategies, catering to the exclusive needs of patients with rare diseases. To illustrate, the Genetic Alliance UK, a national charity based in the UK dedicated to helping those affected by genetic, rare and undiagnosed conditions, reported in February 2024 that 3.5 million people in the UK are living with a rare disease and 1 in 17 individuals will at some stage in their life be impacted by a rare condition. Hence, as the escalated prevalence of rare diseases persists, it is fostering the growth of the personalized medicine market.

The personalized medicine market covered in this report is segmented –

1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness

2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications

3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users

Subsegments:

1) By Personalized Medicine Diagnostics: Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging

2) By Personalized Medicine Therapeutics: Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products

3) By Personalized Medical Care: Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring

4) By Personalized Nutrition And Wellness: Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs

What Trends Are Currently Influencing Growth In The Personalized Medicine Market?

Advancements in technology are emerging as a dominant trend in the personalized medicine sector. The implementation of novel technologies is being leveraged by leading companies in the personalized medicine market to maintain their market position. For instance, OM1, a healthcare firm based in the US that uses real-world data and artificial intelligence (AI) to support healthcare providers, registered a patent for an AI-driven platform in April 2023 to promote personalized medicine. This innovation makes use of wide-scale data analysis to draw valuable conclusions about diagnoses, disease progression, and treatment responses. It is particularly valuable because it provides customized healthcare information, improves healthcare providers’ decision-making process, and speeds up clinical trials by efficiently identifying suitable candidates, leading to the further progression of personalized medicine in the market.

Who Are The Primary Players Operating Across The Global Personalized Medicine Market?

Major companies operating in the personalized medicine market include Bayer AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, AstraZeneca plc, Abbott Laboratories, Danaher Corporation, Eli Lilly and Company, Decode Genetics Inc., GE HealthCare Technologies Inc., Roche Diagnostics, Genentech Inc., Biogen Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Myriad Genetics Inc., Verily Life Sciences LLC, Guardant Health Inc., Tempus Labs, Oxford Nanopore Technologies, Foundation Medicine Inc., NanoString Technologies Inc., Exagen Inc., Asuragen Inc., Personal Genome Diagnostics, Precision Biologics Inc., Strata Oncology, Genelex Corp, Invitae Corporation, Color Genomics, Helix OpCo LLC, 10x Genomics Inc., Agena Bioscience Inc., Natera Inc., Becton Dickinson and Company, PerkinElmer Inc., Sophia Genetics, Genomic Vision, Personalis Inc.

https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report

Which Region Offers The Most Growth Potential For The Personalized Medicine Market Through 2029?

North America was the largest region in the personalized medicine market in 2024. Asia-pacific is expected to be the fastest-growing region in the global personalized medicine market during the forecast period. The regions covered in the personalized medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10272&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Personalized Medicine Market Growth Performance Trended Historically, And What Lies Ahead?

The size of the personalized medicine market has experienced robust growth in the past few years. It is projected to expand from $386.27 billion in 2024 to $422.9 billion in 2025, registering a compound annual growth rate (CAGR) of 9.5%. The upsurge during the historical period can be credited to the emergence of companion diagnostics, the emphasis on patient-oriented healthcare, a shift in the drug development model, efforts to contain healthcare costs, and a rising prevalence of chronic diseases.

The market size for personalized medicine is anticipated to undergo a substantial growth spurt in the approaching years. It’s expected to project a value of $650.59 billion by 2029, with a compound annual growth rate (CAGR) of 11.4%. Several factors fueling this growth in the forecasted timeline include the persistent development in genomics, the surge in biomarker identification, an increase in implementing telemedicine, supportive regulatory structures, and enhanced cooperation and data sharing. Key trends identified for the same period consist of the incorporation of artificial intelligence (AI), developments in genomic sequencing, data collaboration and analytics, immunotherapy and specific treatment strategies, patient agency and educated decision-making, along with alliances and agreements.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10272&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Personalized Medicine Market?

The increasing occurrence of uncommon illnesses is anticipated to propel the personalized medicine market’s growth. This surge pertains to an escalating count of individuals identified with conditions such as Klinefelter Syndrome, Aarskog Syndrome, and Abetalipoproteinemia. Personalized medicine provides customised treatment choices, catering to the exclusive needs of patients with unusual diseases. For example, Genetic Alliance UK, a national charity based in the UK that aids people afflicted by genetic, rare, and undiagnosed conditions, indicated that as of February 2024, the UK had 3.5 million residents living with an unusual condition. Furthermore, one in every 17 individuals will experience a rare condition at some point in their lives. Consequently, as the frequency of rare diseases continues to escalate, it is contributing to the growth of the personalized medicine market.

Which Key Market Segments Comprise the Personalized Medicine Market and Drive Its Revenue Growth?

The personalized medicine market covered in this report is segmented –

1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness

2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications

3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users

Subsegments:

1) By Personalized Medicine Diagnostics: Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging

2) By Personalized Medicine Therapeutics: Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products

3) By Personalized Medical Care: Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring

4) By Personalized Nutrition And Wellness: Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=10272&type=smp

Which Areas Are Leading Regions in the Personalized Medicine Market Expansion Across the Globe?

North America was the largest region in the personalized medicine market in 2024. Asia-pacific is expected to be the fastest-growing region in the global personalized medicine market during the forecast period. The regions covered in the personalized medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Strategic Trends Steering thePersonalized Medicine Market Direction?

Advancements in technology are becoming an increasingly prevalent trend in the field of personalized medicine. Leading companies in the personalized medicine market are turning to new technology solutions to maintain their dominance. For example, in April 2023, OM1, a US-based health care company that uses real-world data and artificial intelligence (AI) to aid health care providers, obtained a patent for its AI-driven platform designed to progress personalized medicine. The platform utilizes extensive data analysis to draw relevant findings about diagnoses, progression, and response-to-treatment information. This technology’s relevance mainly lies in its ability to provide tailored healthcare results, empower healthcare providers to make knowledgeable decisions, and speed up clinical trials by identifying appropriate candidates in an effective manner, further propelling the advancement of personalized medicine in the market.

View the full report here:

https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report

How Is the Personalized Medicine Market Conceptually Defined?

Personalized medicine is tailoring medical treatment to an individual’s specific genetic, environmental, and lifestyle factors by considering an individual’s unique characteristics to help prevent, diagnose, and treat disease. It seeks to deliver the correct therapies to the right patients at the right time.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10272

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Personalized Medicine Market Growth Performance Trended Historically, And What Lies Ahead?

The size of the personalized medicine market has experienced robust growth in the past few years. It is projected to expand from $386.27 billion in 2024 to $422.9 billion in 2025, registering a compound annual growth rate (CAGR) of 9.5%. The upsurge during the historical period can be credited to the emergence of companion diagnostics, the emphasis on patient-oriented healthcare, a shift in the drug development model, efforts to contain healthcare costs, and a rising prevalence of chronic diseases.

The market size for personalized medicine is anticipated to undergo a substantial growth spurt in the approaching years. It’s expected to project a value of $650.59 billion by 2029, with a compound annual growth rate (CAGR) of 11.4%. Several factors fueling this growth in the forecasted timeline include the persistent development in genomics, the surge in biomarker identification, an increase in implementing telemedicine, supportive regulatory structures, and enhanced cooperation and data sharing. Key trends identified for the same period consist of the incorporation of artificial intelligence (AI), developments in genomic sequencing, data collaboration and analytics, immunotherapy and specific treatment strategies, patient agency and educated decision-making, along with alliances and agreements.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10272&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Personalized Medicine Market?

The increasing occurrence of uncommon illnesses is anticipated to propel the personalized medicine market’s growth. This surge pertains to an escalating count of individuals identified with conditions such as Klinefelter Syndrome, Aarskog Syndrome, and Abetalipoproteinemia. Personalized medicine provides customised treatment choices, catering to the exclusive needs of patients with unusual diseases. For example, Genetic Alliance UK, a national charity based in the UK that aids people afflicted by genetic, rare, and undiagnosed conditions, indicated that as of February 2024, the UK had 3.5 million residents living with an unusual condition. Furthermore, one in every 17 individuals will experience a rare condition at some point in their lives. Consequently, as the frequency of rare diseases continues to escalate, it is contributing to the growth of the personalized medicine market.

Which Key Market Segments Comprise the Personalized Medicine Market and Drive Its Revenue Growth?

The personalized medicine market covered in this report is segmented –

1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness

2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications

3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users

Subsegments:

1) By Personalized Medicine Diagnostics: Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging

2) By Personalized Medicine Therapeutics: Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products

3) By Personalized Medical Care: Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring

4) By Personalized Nutrition And Wellness: Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=10272&type=smp

Which Areas Are Leading Regions in the Personalized Medicine Market Expansion Across the Globe?

North America was the largest region in the personalized medicine market in 2024. Asia-pacific is expected to be the fastest-growing region in the global personalized medicine market during the forecast period. The regions covered in the personalized medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Strategic Trends Steering thePersonalized Medicine Market Direction?

Advancements in technology are becoming an increasingly prevalent trend in the field of personalized medicine. Leading companies in the personalized medicine market are turning to new technology solutions to maintain their dominance. For example, in April 2023, OM1, a US-based health care company that uses real-world data and artificial intelligence (AI) to aid health care providers, obtained a patent for its AI-driven platform designed to progress personalized medicine. The platform utilizes extensive data analysis to draw relevant findings about diagnoses, progression, and response-to-treatment information. This technology’s relevance mainly lies in its ability to provide tailored healthcare results, empower healthcare providers to make knowledgeable decisions, and speed up clinical trials by identifying appropriate candidates in an effective manner, further propelling the advancement of personalized medicine in the market.

View the full report here:

https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report

How Is the Personalized Medicine Market Conceptually Defined?

Personalized medicine is tailoring medical treatment to an individual’s specific genetic, environmental, and lifestyle factors by considering an individual’s unique characteristics to help prevent, diagnose, and treat disease. It seeks to deliver the correct therapies to the right patients at the right time.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10272

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the Personalized Medicine Market Growth Performance Trended Historically, And What Lies Ahead?#_x000D_

The size of the personalized medicine market has experienced robust growth in the past few years. It is projected to expand from $386.27 billion in 2024 to $422.9 billion in 2025, registering a compound annual growth rate (CAGR) of 9.5%. The upsurge during the historical period can be credited to the emergence of companion diagnostics, the emphasis on patient-oriented healthcare, a shift in the drug development model, efforts to contain healthcare costs, and a rising prevalence of chronic diseases._x000D_

_x000D_

The market size for personalized medicine is anticipated to undergo a substantial growth spurt in the approaching years. It’s expected to project a value of $650.59 billion by 2029, with a compound annual growth rate (CAGR) of 11.4%. Several factors fueling this growth in the forecasted timeline include the persistent development in genomics, the surge in biomarker identification, an increase in implementing telemedicine, supportive regulatory structures, and enhanced cooperation and data sharing. Key trends identified for the same period consist of the incorporation of artificial intelligence (AI), developments in genomic sequencing, data collaboration and analytics, immunotherapy and specific treatment strategies, patient agency and educated decision-making, along with alliances and agreements._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=10272&type=smp_x000D_

_x000D_

#What Are the Major Market Drivers Behind the Rising Adoption of Personalized Medicine Market?#_x000D_

The increasing occurrence of uncommon illnesses is anticipated to propel the personalized medicine market’s growth. This surge pertains to an escalating count of individuals identified with conditions such as Klinefelter Syndrome, Aarskog Syndrome, and Abetalipoproteinemia. Personalized medicine provides customised treatment choices, catering to the exclusive needs of patients with unusual diseases. For example, Genetic Alliance UK, a national charity based in the UK that aids people afflicted by genetic, rare, and undiagnosed conditions, indicated that as of February 2024, the UK had 3.5 million residents living with an unusual condition. Furthermore, one in every 17 individuals will experience a rare condition at some point in their lives. Consequently, as the frequency of rare diseases continues to escalate, it is contributing to the growth of the personalized medicine market._x000D_

_x000D_

#Which Key Market Segments Comprise the Personalized Medicine Market and Drive Its Revenue Growth?#_x000D_

The personalized medicine market covered in this report is segmented – _x000D_

_x000D_

1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness_x000D_

2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications_x000D_

3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Personalized Medicine Diagnostics: Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging_x000D_

2) By Personalized Medicine Therapeutics: Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products_x000D_

3) By Personalized Medical Care: Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring_x000D_

4) By Personalized Nutrition And Wellness: Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=10272&type=smp_x000D_

_x000D_

#Which Areas Are Leading Regions in the Personalized Medicine Market Expansion Across the Globe?#_x000D_

North America was the largest region in the personalized medicine market in 2024. Asia-pacific is expected to be the fastest-growing region in the global personalized medicine market during the forecast period. The regions covered in the personalized medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Are the Strategic Trends Steering thePersonalized Medicine Market Direction?#_x000D_

Advancements in technology are becoming an increasingly prevalent trend in the field of personalized medicine. Leading companies in the personalized medicine market are turning to new technology solutions to maintain their dominance. For example, in April 2023, OM1, a US-based health care company that uses real-world data and artificial intelligence (AI) to aid health care providers, obtained a patent for its AI-driven platform designed to progress personalized medicine. The platform utilizes extensive data analysis to draw relevant findings about diagnoses, progression, and response-to-treatment information. This technology’s relevance mainly lies in its ability to provide tailored healthcare results, empower healthcare providers to make knowledgeable decisions, and speed up clinical trials by identifying appropriate candidates in an effective manner, further propelling the advancement of personalized medicine in the market._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report_x000D_

_x000D_

#How Is the Personalized Medicine Market Conceptually Defined?#_x000D_

Personalized medicine is tailoring medical treatment to an individual’s specific genetic, environmental, and lifestyle factors by considering an individual’s unique characteristics to help prevent, diagnose, and treat disease. It seeks to deliver the correct therapies to the right patients at the right time._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10272_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the personalized medicine industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#How Has The Personalized Medicine Market Growth Evolved From 2024 To 2025, And What’s Ahead?#_x000D_

The size of the personalized medicine market has seen a rapid upsurge in the recent past. Projections indicate a growth from $386.27 billion in 2024 to a substantial $426.82 billion in 2025, marking a compound annual growth rate (CAGR) of 10.5%. This impressive growth during the historic phase can be credited to factors such as the emergence of companion diagnostics, patient-centered healthcare, a noticeable shift in drug development paradigm, measures to control healthcare costs, and the rising prevalence of chronic ailments._x000D_

_x000D_

The market for personalized medicine is predicted to expand rapidly in the forthcoming years, reaching a value of $662.67 billion in 2029, with a compound annual growth rate (CAGR) of 11.6%. Factors contributing to this growth during the projected period include ongoing advancements in genomics, the proliferation of biomarker discovery, the rising use of telemedicine, favorable regulatory frameworks and support, as well as collaboration and information exchange. Key trends projected for the forecast period encompass the application of artificial intelligence (AI), progress in genomic sequencing, the integration and analysis of data, focused therapies and immunotherapy, patient empowerment and informed decision-making, as well as alliances and partnerships._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=10272&type=smp_x000D_

_x000D_

#How Are Key Drivers in the Industry Acting as Catalysts for the Growth of thePersonalized Medicine Market?#_x000D_

The personalized medicine market is expected to increase, driven by a rising occurrence of infrequent conditions. Such growth is largely attributed to the escalating count of persons diagnosed with conditions such as Klinefelter Syndrome, Aarskog Syndrome, and Abetalipoproteinemia. Personalized medicine, offering custom-made treatment approaches, caters to the specific requirements of patients with rare conditions. Taking an example from February 2024, Genetic Alliance UK, a national charity operating in the UK and supporting individuals impacted by genetic, rare or unidentified diseases, reported that 3.5 million people in the UK are grappling with a rare disease, and 1 in every 17 people will be touched by such a condition in their life span. Consequently, as the occurrence of rare diseases keeps on rising, it’s propelling the enlargement of the personalized medicine market._x000D_

_x000D_

#Which Segments in the Personalized Medicine Offer the Most Growth?#_x000D_

The personalized medicine market covered in this report is segmented –_x000D_

_x000D_

1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness_x000D_

2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications_x000D_

3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Personalized Medicine Diagnostics: Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging_x000D_

2) By Personalized Medicine Therapeutics: Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products_x000D_

3) By Personalized Medical Care: Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring_x000D_

4) By Personalized Nutrition And Wellness: Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=10272&type=smp_x000D_

_x000D_

#What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of thePersonalized Medicine Market?# Market?#_x000D_

North America was the largest region in the personalized medicine market in 2024. Asia-pacific is expected to be the fastest-growing region in the global personalized medicine market during the forecast period. The regions covered in the personalized medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Are the Current Market Growth and Trends in the Personalized Medicine Industry?#_x000D_

The rise of technological innovations is a prominent trend observed in the personalized medicine market. Major organizations in this field are leveraging new tech solutions to maintain their market standing. For example, in April 2023, U.S -based healthcare company, OM1, which uses real-world data and AI to support healthcare practitioners, patented an AI-driven platform to fast-track personalized medicine. This technology uses comprehensive data analysis to yield valuable insights related to diagnoses, disease progression and response to treatments. The key benefits of this technology are providing customized healthcare suggestions, enhancing decision-making abilities of healthcare providers, and speeding up clinical trials by swiftly identifying appropriate candidates. All these aspects significantly propel the growth of personalized medicine in the market._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report_x000D_

_x000D_

#What Are the Key Elements That Define the Personalized Medicine Market?#_x000D_

Personalized medicine is tailoring medical treatment to an individual’s specific genetic, environmental, and lifestyle factors by considering an individual’s unique characteristics to help prevent, diagnose, and treat disease. It seeks to deliver the correct therapies to the right patients at the right time._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10272_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Primary Drivers Are Supporting the Continued Market Growth of thePersonalized Medicine Market?

The personalized medicine market’s growth is anticipated to be propelled by an increase in the number of rare diseases. This surge refers to the expanding population identified with disorders such as Klinefelter Syndrome, Aarskog Syndrome, and Abetalipoproteinemia. Personalized medicine presents customized treatment plans which cater to the unique healthcare needs of patients suffering from rare diseases. For example, Genetic Alliance UK, a national charity based in the UK that supports individuals impacted by genetic, rare, and undiagnosed conditions, reported in February 2024, that there are 3.5 million people living with a rare condition in the UK, with 1 in 17 individuals likely to suffer from a rare condition at any time in their lifetime. Thus, as the number of rare disease increases, it contributes to the growth of the personalized medicine market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10272&type=smp

#What is the Anticipated CAGR of the Personalized Medicine Market, and What Factors Will Drive It?

The size of the personalized medicine market has seen a significant increase lately. The market, which was worth $386.27 billion in 2024, is projected to escalate to $426.82 billion in 2025 with a compound annual growth rate (CAGR) of 10.5%. Factors contributing to the growth in the past have been the emergence of companion diagnostics, the rise of healthcare focused on the patient, a shift in drug development paradigms, efforts towards healthcare cost containment, and a heightened prevalence of chronic diseases.

The market size of personalized medicine is forecasted to witness a swift expansion in the coming years, ballooning to $662.67 billion in 2029 with an 11.6% compound annual growth rate (CAGR). The projected rise over the forecast period can be ascribed to sustained advancements in genomics, the broadening of biomarker identification, increased usage of telemedicine, supportive regulatory frameworks, and cooperative data sharing. The forecast period is also expected to see significant trends such as the implementation of artificial intelligence (AI), progress in genomic sequencing, the consolidation of data and analytics, immunotherapy and individualised treatments, patient empowerment through augmented decision-making, and collaborative alliances.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10272

How Are Consumer Market Innovations Shaping the Current and Future Landscape of thePersonalized Medicine Market?

The advancement of technology is an emerging trend in the personalized medicine market. To maintain their market position, leading companies in the personalized medicine sector are adopting revolutionary technologies. For example, in April 2023, OM1, a healthcare company based in the United States that makes use of real-world data and AI to support healthcare providers, secured a patent for its AI-driven platform aimed at boosting personalized medicine. This platform uses large-scale data analysis to generate pertinent insights into diagnosis, progression, and the response to treatment. Its importance is underscored by its capability to provide customized healthcare suggestions, improve healthcare providers’ decision-making process, and expedite clinical trials by identifying appropriate candidates effectively, thereby aiding the progress of personalized medicine in the market.

Who Are the Key Market Players Influencing the Growth of the Corn and Personalized Medicine Industry?

Major companies operating in the personalized medicine market include Bayer AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, AstraZeneca plc, Abbott Laboratories, Danaher Corporation, Eli Lilly and Company, Decode Genetics Inc., GE HealthCare Technologies Inc., Roche Diagnostics, Genentech Inc., Biogen Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Myriad Genetics Inc., Verily Life Sciences LLC, Guardant Health Inc., Tempus Labs, Oxford Nanopore Technologies, Foundation Medicine Inc., NanoString Technologies Inc., Exagen Inc., Asuragen Inc., Personal Genome Diagnostics, Precision Biologics Inc., Strata Oncology, Genelex Corp, Invitae Corporation, Color Genomics, Helix OpCo LLC, 10x Genomics Inc., Agena Bioscience Inc., Natera Inc., Becton Dickinson and Company, PerkinElmer Inc., Sophia Genetics, Genomic Vision, Personalis Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report

Which Key Market Segments Comprise the Personalized Medicine Market and Drive Its Revenue Growth?

The personalized medicine market covered in this report is segmented –

1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness

2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications

3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users

Subsegments:

1) By Personalized Medicine Diagnostics: Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging

2) By Personalized Medicine Therapeutics: Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products

3) By Personalized Medical Care: Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring

4) By Personalized Nutrition And Wellness: Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=10272&type=smp

Which Regions Are Emerging as Leaders in the Personalized Medicine Market?

North America was the largest region in the personalized medicine market in 2024. Asia-pacific is expected to be the fastest-growing region in the global personalized medicine market during the forecast period. The regions covered in the personalized medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Personalized Medicine Market 2025, By The Business Research Company:

Anti-Money Laundering Software Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/anti-money-laundering-software-global-market-report

Mobile Money Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/mobile-money-global-market-report

Personal Finance Software Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/personal-finance-software-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the personalized medicine market size evolved in recent years?

The market size for personalized medicine has experienced fast-paced growth in the past few years. The market is predicted to expand from $386.27 billion in 2024 to $426.82 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 10.5%. Factors contributing to the growth during the historic period include the emergence of companion diagnostics, a shift towards patient-centric healthcare, a transformation in drug development methodologies, efforts to contain healthcare costs, and a rising prevalence of chronic diseases.

What are the predictions for the personalized medicine market size in the coming years?

Get your personalized medicine market report here!

https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report

What key factors are fueling the growth of the personalized medicine market?

The burgeoning occurrence of uncommon illnesses is forecasted to stimulate the expansion of the personalized medicine market. This surge pertains to an escalating count of individuals suffering from conditions like Klinefelter Syndrome, Aarskog Syndrome, and Abetalipoproteinemia. Personalized medication provides custom-made treatments, meeting the singular requirements of patients with rare diseases. Illustratively, the Genetic Alliance UK, a national charity based in the UK aiding those impacted by genetic, rare, and undiagnosed illnesses, reported in February 2024 that within the UK, 3.5 million individuals are coping with a rare ailment and 1 among 17 individuals will confront a peculiar disease at some juncture in their lives. Therefore, as the escalating occurrence of unusual diseases persists, it’s propelling the growth of the personalized medicine market.

How is the global personalized medicine market divided into key segments?

The personalized medicine market covered in this report is segmented –

1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness

2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications

3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users

Subsegments:

1) By Personalized Medicine Diagnostics: Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging

2) By Personalized Medicine Therapeutics: Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products

3) By Personalized Medical Care: Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring

4) By Personalized Nutrition And Wellness: Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10272&type=smp

Who are the key firms paving the way for growth in the personalized medicine market?

Major companies operating in the personalized medicine market include Bayer AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, AstraZeneca plc, Abbott Laboratories, Danaher Corporation, Eli Lilly and Company, Decode Genetics Inc., GE HealthCare Technologies Inc., Roche Diagnostics, Genentech Inc., Biogen Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Myriad Genetics Inc., Verily Life Sciences LLC, Guardant Health Inc., Tempus Labs, Oxford Nanopore Technologies, Foundation Medicine Inc., NanoString Technologies Inc., Exagen Inc., Asuragen Inc., Personal Genome Diagnostics, Precision Biologics Inc., Strata Oncology, Genelex Corp, Invitae Corporation, Color Genomics, Helix OpCo LLC, 10x Genomics Inc., Agena Bioscience Inc., Natera Inc., Becton Dickinson and Company, PerkinElmer Inc., Sophia Genetics, Genomic Vision, Personalis Inc.

Which trends are expected to transform the personalized medicine market?

Some of the leading entities in the personalized medicine market are Bayer AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, AstraZeneca plc, Abbott Laboratories and Danaher Corporation. Other significant players include Eli Lilly and Company, Decode Genetics Inc., GE HealthCare Technologies Inc., Roche Diagnostics, Genentech Inc., Biogen Inc. and Illumina Inc. Entities like Qiagen N.V., Exact Sciences Corporation, Myriad Genetics Inc., Verily Life Sciences LLC and Guardant Health Inc., are also key contributors. Tempus Labs, Oxford Nanopore Technologies, Foundation Medicine Inc., NanoString Technologies Inc., and Exagen Inc. are noteworthy participants in this sector. Asuragen Inc., Personal Genome Diagnostics, Precision Biologics Inc., Strata Oncology and Genelex Corp are firm presences too. Invitae Corporation, Color Genomics, Helix OpCo LLC, 10x Genomics Inc., and Agena Bioscience Inc. are also part of this industry. Lastly, Natera Inc., Becton Dickinson and Company, PerkinElmer Inc., Sophia Genetics, Genomic Vision, and Personalis Inc. are also major players in the personalized medicine market.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10272

What regions are contributing significantly to the growth of the personalized medicine market?

North America was the largest region in the personalized medicine market in 2024. Asia-pacific is expected to be the fastest-growing region in the global personalized medicine market during the forecast period. The regions covered in the personalized medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Synthetic Pigments Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/synthetic-pigments-global-market-report

Surface Active Agents Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/surface-active-agents-global-market-report

Paints And Coatings Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/paints-and-coatings-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Growth Opportunities are Expected to Drive the Personalized Medicine Market’s CAGR Through 2034?

In recent years, the size of the personalized medicine market has seen significant expansion rapidly. It’s estimated to rise from $386.27 billion in 2024 to $426.82 billion in 2025, showcasing a compound annual growth rate (CAGR) of 10.5%. Several factors have contributed to this growth during the historic period, including the emergence of companion diagnostics, the rise of patient-focused healthcare, a shift in drug development paradigms, containment of healthcare costs, and an increase in chronic disease prevalence.

In the coming years, the market size of personalized medicine is predicted to experience rapid expansion. The projected growth is to reach $662.67 billion by 2029, with a compound annual growth rate (CAGR) of 11.6%. Several factors contribute to this growth, including the ongoing advancements in genomics, increased discovery of biomarkers, wider adoption of telemedicine, supportive regulatory authority and frameworks, as well as cooperation and data sharing. Key trends for this period encompass the incorporation of artificial intelligence (AI), progress in genomic sequencing, integration and analysis of data, immunotherapy, targeted treatments, patient empowerment, informed decision making, and strategic alliances and partnerships.

Which Drivers Are Expected to Have the Greatest Impact on the personalized medicine Market’s Growth?

The growth of the personalized medicine market is anticipated to be driven by the increasing occurrences of rare diseases. This boost is linked to the surge in the number of individuals diagnosed with conditions such as Klinefelter Syndrome, Aarskog Syndrome, and Abetalipoproteinemia. Personalized medicine provides treatments designed to meet the distinct needs of patients with rare diseases. For example, the Genetic Alliance UK, a national charity supporting those affected by genetic, rare, and undiagnosed conditions, reported in February 2024 that there are 3.5 million people in the UK living with a rare condition, with 1 in 17 subject to a rare condition at some stage in their lives. Therefore, as the prevalence of rare diseases keeps rising, it is driving the growth of the personalized medicine market.

Explore Comprehensive Insights Into The Global Personalized Medicine Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10272&type=smp

What Are the Leading Industry Players Dominating the Personalized Medicine Market?

Major companies operating in the personalized medicine market include:

• Bayer AG_x000D_

• Novartis AG_x000D_

• Thermo Fisher Scientific Inc._x000D_

• GlaxoSmithKline plc_x000D_

• AstraZeneca plc_x000D_

What Are the Latest Trends Leading to Disruption in the Personalized Medicine Market?

Technological progress is a growing trend in the personalized medicine market. To maintain their market position, major companies in this field are implementing new technologies. For example, OM1, a healthcare company based in the US that uses real-world data and artificial intelligence (AI) to support healthcare providers, obtained a patent for an AI-powered platform designed to fast-track personalized medicine in April 2023. This technology uses large-scale data analysis to create useful insights related to diagnoses, disease progression, and treatment responses. The importance of this technology is seen in its ability to provide customized healthcare information, improve decision-making for healthcare providers, and accelerate clinical trials by identifying appropriate candidates in a more efficient manner, all of which drive forward the development of personalized medicine in the market.

Secure Your Global Personalized Medicine Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report

What Are the Core Categories and Segments in the Personalized Medicine Market Driving Demand and Growth?

The personalized medicine market covered in this report is segmented –

1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness

2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications

3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users

Subsegments:

1) By Personalized Medicine Diagnostics: Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging

2) By Personalized Medicine Therapeutics: Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products

3) By Personalized Medical Care: Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring

4) By Personalized Nutrition And Wellness: Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs

Which Regions Are Significant to the Growth of the Personalized Medicine Market?

North America was the largest region in the personalized medicine market in 2024. Asia-pacific is expected to be the fastest-growing region in the global personalized medicine market during the forecast period. The regions covered in the personalized medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Personalized Medicine Market Classified and Defined in Market Analysis?

Personalized medicine is tailoring medical treatment to an individual’s specific genetic, environmental, and lifestyle factors by considering an individual’s unique characteristics to help prevent, diagnose, and treat disease. It seeks to deliver the correct therapies to the right patients at the right time.

Browse Through More Similar Reports By The Business Research Company:

Synthetic Pigments Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/synthetic-pigments-global-market-report

Surface Active Agents Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/surface-active-agents-global-market-report

Paints And Coatings Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/paints-and-coatings-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: